Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy

Cardiovascular Pathology

Volumn 19, Issue 5, 2010, Pages

  Lebrecht, Dirk ^a   Kirschner, Janbernd ^a   Geist, Andrea ^a   Haberstroh, Jörg ^a   Walker, Ulrich A ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Felix Platter Spital   (Switzerland)

Author keywords

Calcium; Doxorubicin; Mitochondria; Mitochondrial DNA; Respiratory chain

Indexed keywords

CALCIUM; CYCLOOXYGENASE 1; CYTOCHROME C OXIDASE; DOXORUBICIN; MITOCHONDRIAL DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; MALE; MITOCHONDRION; MORPHOLOGY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; ULTRASTRUCTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CALCIUM; CARDIOMYOPATHIES; DNA, MITOCHONDRIAL; DOXORUBICIN; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX IV; HOMEOSTASIS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, HEART; RATS; RATS, WISTAR;

EID: 77956437166     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2009.06.006     Document Type: Article

References (34)

1. Singal PK, and Iliskovic N Doxorubicin-induced cardiomyopathy N Engl J Med 339 1998 900 905
2. Nohl H Demonstration of the existence of an organo-specific NADH dehydrogenase in heart mitochondria Eur J Biochem 169 1987 585 591
3. Lebrecht D, Setzer B, Ketelsen UP, Haberstroh J, and Walker UA Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy Circulation 108 2003 2423 2429
4. 2+ overload Eur J Biochem 178 1988 489 501
5. 2+ in the regulation of energy metabolism Dev Neurosci 15 1993 165 173
6. Das AM, and Harris DA Control of mitochondrial ATP synthase in heart cells: inactive to active transitions caused by beating or positive inotropic agents Cardiovasc Res 24 1990 411 417
7. 2+ transport by mitochondria and its possible role in the cardiac contraction-relaxation cycle Circ Res 35 Suppl 3 1974 83 90
8. Olson HM, Young DM, Prieur DJ, LeRoy AF, and Reagan RL Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits Am J Pathol 77 1974 439 454
9. 2+ by mitochondria from rabbit heart, liver, and kidney after doxorubicin or digoxin/doxorubicin treatment Exp Mol Pathol 31 3 1979 440 451 (Pubitemid 10199518)
10. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, and Schapira AH Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases FEBS Letters 345 1994 50 54
11. 2+: an alternate mechanism for the cardiotoxicity of doxorubicin Toxicol Appl Pharmacol 107 1991 117 128
12. Jekabsone A, Ivanoviene L, Brown GC, and Borutaite V Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release J Mol Cell Cardiol 35 2003 803 809
13. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, and Orrenius S Cytochrome c release from mitochondria proceeds by a two-step process Proc Natl Acad Sci U S A 99 2002 1259 1263
14. Zhou S, Starkov A, Froberg MK, Leino RL, and Wallace KB Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin Cancer Res 61 2 2001 771 777
15. 2+ increase by doxorubicin in cardiac myocytes Biochem J 281 3 1992 871 878
16. Della Torre P, Podesta A, Pinciroli G, Iatropoulos MJ, and Mazue G Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats Toxicol Pathol 24 1996 398 402
17. Hammond EL, Sayer D, Nolan D, Walker UA, Ronde A, Montaner JS, Cote HC, Gahan ME, Cherry CL, Wesselingh SL, Reiss P, and Mallal S Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study J Clinical Virol 27 2003 97 110
18. DiMauro S, Mendell JR, Sahenk Z, Bachman D, Scarpa A, Scofield RM, and Reiner C Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency Neurology 30 1980 795 804
19. Anderson WA The localization of cytochrome c oxidase activity during mitochondrial specialization in spermiogenesis of prosobranch snails J Histochem Cytochem 18 1970 201 210
20. Chaplin AJ Calcium pyrophosphate. Histological characterization of crystals in pseudogout Arch Pathol Lab Med 100 1976 12 15
21. Kawamata S The distribution of calcium in undecalcified bone as revealed by an improved pyro-antimonate method Histochem J 24 1992 275 278
22. 2+ granules in a hypertrophied heart exposed to adriamycin Can J Physiol Pharmacol 62 9 1984 1239 1244
23. Barazzoni R, Short KR, and Nair KS Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart J Biol Chem 275 5 2000 3343 3347
24. Zorzato F, Salviati G, Facchinetti T, and Volpe P Doxorubicin induces calcium release from terminal cisternae of skeletal muscle. A study on isolated sarcoplasmic reticulum and chemically skinned fibers J Biol Chem 260 1985 7349 7355
25. 2+ increase are reciprocally modulated in rat cardiomyocytes Exp Mol Med 38 5 2006 535 545
26. 2+ exchange of dog heart sarcolemmal vesicles FEBS Lett 130 1981 184 186 (Pubitemid 11008557)
27. Keung EC, Toll L, Ellis M, and Jensen RA L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations J Clin Invest 87 1991 2108 2113
28. Lebrecht D, and Walker UA Role of mtDNA lesions in anthracycline cardiotoxicity Cardiovasc Toxicol 7 2007 108 113
29. 2+) in rat pulmonary artery smooth muscle cells J Physiol 516 1999 139 147
30. Singal PK, Deally CM, and Weinberg LE Subcellular effects of adriamycin in the heart: a concise review J Mol Cell Cardiol 19 1987 817 828
31. Wexler LH, Andrich MP, Venzon D, Berg SL, Weaver-McClure L, Chen CC, Dilsizian V, Avilia N., Jarosinski P, Balis FM, Poplack DG, and Horowitz ME Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin J Clin Oncol 14 1996 362 372
32. Swain SM, Whaley FS, Gerber MC, Weisberg S, York M, Spicer D, Jones SE, Wadler S, Desai A, Vogel C, Speyer J, Mittelman A, Reddy S, Pendergrass K, Velez-Garcia E, Ewer MS, Bianchine JR, and Gams RA Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer J Clin Oncol 15 1997 1318 1332 (Pubitemid 27167363)
33. Khan MF, Varadharaj S, Shobha J, Shobha JC, Naidu M, Naidu MU, Parinandi NL, Kutala VK, and Kuppusamy P C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes J Cardiovasc Pharmacol 47 1 2006 9 20
34. 2+ increase and apoptosis in rat cardiomyocytes Biol Pharm Bull 31 5 2008 809 815